Introduction: high risk HPV is the perpetrator of cervical cancer disease, however screening and vaccination is not included in cervical cancer
Introduction
Cervical cancer disease causes reproductive ill health and is among leading global women cancers accounting for at least 68% annual women mortality in the developing world [1, 2] . The disease is preceded by pre cancer status identified by detection of abnormal cells in cervical smears. The Bethesda system (TBS) [3] , is employed to classify cells as per their specific atypia such as koilocytosis [4] [5] [6] [7] [8] . In Kenya, screening for HR HPV subtypes is not included in the cervical cancer prevention policy and neither is vaccination. This study examined HR HPV prediction to cervical cancer development, in addition to other cervical cell atypia manifestation determinants, with the aim of preventing progression of the disease.
Methods
We assessed the association of HR 16/18 HPV and socio-demographic characteristics and practices with cervical cytomorphologic presentations. This was a descriptive study among women patients attending the reproductive health clinic of Nakuru County referral hospital during the period of January 2014 to December 2014. Ethical approval for this study was obtained from the Kenyatta University Ethics Review Committee (KUERC-KU/R/COMM/51/228) and Nakuru
County Referral Hospital Research and Ethics Committee
(RII/VOL.I/08) before commencement of research. A total of 142 study subjects were consecutively recruited into the study during reproductive health clinic visits. A structured closed and open ended questionnaire was administered. Questionnaire administration was conducted through a semi interview process as a number of subjects were illiterate and could not interpret the questions on the list.
Cervical screening by visual cervical inspection (VIA/VILI test) was conducted. Endocervical scrape smear examination for cytomorphological profiling was conducted using the revised 2014 Bethesda classification [3] into four pre cervical cancer study groups of: 1) LSIL; n=35; 2) HSIL; n=59; 3) AGC/AIS; n=8 and 4) ControlNo evidence of pre cervical cancer; n=40. Those above 20 years and were VIA/VILI positive specifically where sexual debutation had begun were included in the study. Pregnant women were not included in the survey as well as those who were not willing to participate in the study. Blood samples were collected and screened for Treponema pallidum and HIV1/2 antibodies [9, 10] . Endocervical specimens were collected for Neisseria gonorrhea, Chlamydia trachomatis and HPV antigen detection [11, 12] , as well as for scrape smears preparations for Pap smear processing and staining. Stained and mounted smears were microscopically examined for cyto-morphological profiling and categorization using the Bethesda system into distinct pre cancer grades [3] . All Pap smear microscopic examinations were conducted at low power X10 for evaluation of cellular sufficiency and for atypia at high power X40. Smear findings were confirmed by a clinical cytologist. Smear microscopic feature images were captured using the Data management and analysis: data capture was done using
Microsoft office Excel software [13] . After clean up to remove outliers data was exported into SPPS statistical software [14] . Descriptive statistics for frequencies and proportions were generated. Chi-square tests were used to determine associations between dependent variables (pre cervical cancer grades) and independent variables (predictors). Further analysis using multivariate logistic regression models were used to determine the magnitudes of associations between study groups and likelihood tendency (OR) of predicting pre cervical cancer sign manifestation at 95% confidence interval).
Ethics approval and consent to participate: ethical approval for this study was obtained from the Kenyatta University Ethics Review Committee (KUERC-KU/R/COMM/51/228) and Nakuru County
Referral Hospital Research and Ethics Committee (RII/VOL.I/08).
Written informed consent was obtained from all the study participants prior to administering the questionnaire and collection of blood specimens and endocervical swabs and scrapes specimens.
Results
The prevalence of cervical atypia from Pap smear test protocol [15] which denoted the grade of pre cervical cancer is shown in Figure 1 .
HSIL pre cancer grade, (Figure 2 Table 3 .
This implies that the recorded high cases of cervical cancer in pilot studies in Nakuru, [7] are due to high risk HPV strains of 16/18. These analyses are similar with those in cross-sectional hospital based study conducted at Nairobi, Kenya in Kenyatta National hospital showing associations between high risk HPV with HSIL in over 70% of high grade lesions and all squamous cell carcinomas detected in these studies [34] . The sexual risk behaviour of the studied populations in Nakuru could have contributed to high risk acquisition of high risk variant of HPV or some proportions of immunosuppressed individuals and possible low vaccination or screening coverage in Nakuru [5, [38] [39] [40] .
High median age which was significantly associated with the pre cervical cancer grades (P<0.0001) was encountered, Table 4 . This result is in harmony with reports in other studies which imply that having advanced age places a woman at risk of developing pre cancer signs within the cervix as a result of diminishing ovarian hormones due to menopause [29, 30] . In addition, lack of medical check in routine screening of cervical cancer may also contribute to high proportion of median age groups, who may detected this when at advanced stage of cancer. Similarly, knowledge on cause of cervical cancer assessed from varied responses obtained from study participants was linked to pre cancer grades (P= 0.002), as displayed in Table 4 . This association could be attributed to low levels of education (P= 0.017) amongst the study participants drawn from the public referral hospital serving Nakuru County residents. Similar studies conducted in other counties in Kenya show consistency in terms of low education levels, illiteracy and ignorance among cervical cancer patients [27, 31] . Eight study participants ( 
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